Impact of Vaccination in Acute COVID-19

University Medical Centre Ljubljana

Status: Completed

Conditions: COVID-19

Treatments: Biological: vaccination

Study type: Observational

Funder types: Other

Identifiers

NCT05198453

Breakthrough covid

Details and patient eligibility

About

The aim of this study was to evaluate the association between vaccination with one of the four SARS-CoV-2 vaccines authorized for use in the European Union-BNT162b2, ChAdOx-1S, mRNA-1273 or Ad.26.COV2.S-and progression to critically severe disease among adult patients with PCR-confirmed acute COVID-19.

Enrollment: 529 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age 18 yers or more
• hospitalized for acute COVID-19
• PCR confirmed infection with SARS-CoV-2

Exclusion criteria

• hospitalized for other conditions

Trial design

529 participants in 2 patient groups

vaccinated patients with COVID-19

Treatment:

Biological: vaccination

unvaccinated patients with COVID-19